Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANIDULAFUNGIN for Antifungal prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 40 adverse event reports in the FDA FAERS database where ANIDULAFUNGIN was used for Antifungal prophylaxis.

Most Reported Side Effects for ANIDULAFUNGIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 234 33.4% 148 134
Multiple organ dysfunction syndrome 108 15.4% 96 50
Off label use 85 12.1% 36 38
Candida infection 61 8.7% 27 18
Death 57 8.1% 57 11
Neutropenia 53 7.6% 29 19
Pneumonia 49 7.0% 41 4
Septic shock 45 6.4% 27 26
Sepsis 42 6.0% 22 11
Condition aggravated 37 5.3% 22 11
Drug resistance 37 5.3% 14 16
Pyrexia 36 5.1% 8 21
Contraindicated product administered 34 4.9% 34 28
Covid-19 pneumonia 32 4.6% 32 28
Respiratory failure 32 4.6% 15 14

Other Indications for ANIDULAFUNGIN

Product used for unknown indication (132) Candida infection (96) Systemic candida (47) Fungal infection (36) Antifungal treatment (30) Bronchopulmonary aspergillosis (28) Aspergillus infection (22) Fungaemia (14) Abdominal infection (13) Enterococcal infection (13)

Other Drugs Used for Antifungal prophylaxis

SULFAMETHOXAZOLE\TRIMETHOPRIM (1,445) POSACONAZOLE (1,032) VORICONAZOLE (709) FLUCONAZOLE (599) CASPOFUNGIN (334) AMPHOTERICIN B (326) ATOVAQUONE (319) MICAFUNGIN (237) ITRACONAZOLE (207) DAPSONE (110)

Related Pages

ANIDULAFUNGIN Full Profile All Antifungal prophylaxis Drugs ANIDULAFUNGIN Demographics ANIDULAFUNGIN Timeline